FDA Approves AstraZeneca's Blockbuster Cancer Drug, Imfinzi, In Combination With Chemo For Non-Small Cell Lung Cancer
J&J, Roche Come Out on Top in S&P Ratings of Strongest Pharma Companies
Trending Stocks This Week as U.S. Equities Notch Their Best Week of 2024
How Should You Play AstraZeneca (AZN) After Q2 Beat, View Raise?
Pharmaron (03759) plans to acquire 80 million yuan of unsubscribed but yet-to-be paid AstraZeneca fund shares held by Jiangsu Yuyue Medical Equipment & Supply.
Pharmaron (03759) has announced to fully leverage its industry-leading position in medical and health fields as well as its globalized industry chain.
AstraZeneca Imfinzi Label Expanded in U.S. for Lung Cancer
Ryand83 OP : $ROCHE HOLDING AG (RHHBY.US)$ $AstraZeneca (AZN.US)$
Ryand83 OP : meant to say 40B
not 50B. Point is that Roche would be dummies to screw us over